These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 7530825)

  • 1. TGF alpha and v-fos cooperation in transgenic mouse epidermis induces aberrant keratinocyte differentiation and stable, autonomous papillomas.
    Wang XJ; Greenhalgh DA; Lu XR; Bickenbach JR; Roop DR
    Oncogene; 1995 Jan; 10(2):279-89. PubMed ID: 7530825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mouse epidermis coexpressing transforming growth factor-alpha and v-fos: acceleration of autonomous papilloma formation and malignant conversion via c-Ha-ras activation.
    Wang XJ; Liefer KM; Greenhalgh DA; Roop DR
    Mol Carcinog; 1999 Dec; 26(4):305-11. PubMed ID: 10569807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paradoxical tumor inhibitory effect of p53 loss in transgenic mice expressing epidermal-targeted v-rasHa, v-fos, or human transforming growth factor alpha.
    Greenhalgh DA; Wang XJ; Donehower LA; Roop DR
    Cancer Res; 1996 Oct; 56(19):4413-23. PubMed ID: 8813135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cooperation between v-fos and v-rasHA induces autonomous papillomas in transgenic epidermis but not malignant conversion.
    Greenhalgh DA; Quintanilla MI; Orengo CC; Barber JL; Eckhardt JN; Rothnagel JA; Roop DR
    Cancer Res; 1993 Nov; 53(21):5071-5. PubMed ID: 7693330
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate promotion of transgenic mice expressing epidermal-targeted v-fos induces rasHA-activated papillomas and carcinomas without p53 mutation: association of v-fos expression with promotion and tumor autonomy.
    Greenhalgh DA; Wang XJ; Eckhardt JN; Roop DR
    Cell Growth Differ; 1995 May; 6(5):579-86. PubMed ID: 7544154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted overexpression of transforming growth factor alpha in the epidermis of transgenic mice elicits hyperplasia, hyperkeratosis, and spontaneous, squamous papillomas.
    Dominey AM; Wang XJ; King LE; Nanney LB; Gagne TA; Sellheyer K; Bundman DS; Longley MA; Rothnagel JA; Greenhalgh DA
    Cell Growth Differ; 1993 Dec; 4(12):1071-82. PubMed ID: 8117621
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transgenic coexpression of v-Ha-ras and transforming growth factor alpha increases epidermal hyperproliferation and tumorigenesis and predisposes to malignant conversion via endogenous c-Ha-ras activation.
    Wang XJ; Greenhalgh DA; Roop DR
    Mol Carcinog; 2000 Mar; 27(3):200-9. PubMed ID: 10708482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTEN loss promotes rasHa-mediated papillomatogenesis via dual up-regulation of AKT activity and cell cycle deregulation but malignant conversion proceeds via PTEN-associated pathways.
    Yao D; Alexander CL; Quinn JA; Porter MJ; Wu H; Greenhalgh DA
    Cancer Res; 2006 Feb; 66(3):1302-12. PubMed ID: 16452183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperplasia, hyperkeratosis and benign tumor production in transgenic mice by a targeted v-fos oncogene suggest a role for fos in epidermal differentiation and neoplasia.
    Greenhalgh DA; Rothnagel JA; Wang XJ; Quintanilla MI; Orengo CC; Gagne TA; Bundman DS; Longley MA; Fisher C; Roop DR
    Oncogene; 1993 Aug; 8(8):2145-57. PubMed ID: 7687760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands.
    Dlugosz AA; Cheng C; Williams EK; Darwiche N; Dempsey PJ; Mann B; Dunn AR; Coffey RJ; Yuspa SH
    Cancer Res; 1995 May; 55(9):1883-93. PubMed ID: 7728756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cooperation between Ha-ras and fos or transforming growth factor alpha overcomes a paradoxic tumor-inhibitory effect of p53 loss in transgenic mouse epidermis.
    Wang XJ; Greenhalgh DA; Donehower LA; Roop DR
    Mol Carcinog; 2000 Oct; 29(2):67-75. PubMed ID: 11074603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesis.
    Wang XJ; Greenhalgh DA; Jiang A; He D; Zhong L; Medina D; Brinkley BR; Roop DR
    Oncogene; 1998 Jul; 17(1):35-45. PubMed ID: 9671312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human keratin-1.bcl-2 transgenic mice aberrantly express keratin 6, exhibit reduced sensitivity to keratinocyte cell death induction, and are susceptible to skin tumor formation.
    Rodríguez-Villanueva J; Greenhalgh D; Wang XJ; Bundman D; Cho S; Delehedde M; Roop D; McDonnell TJ
    Oncogene; 1998 Feb; 16(7):853-63. PubMed ID: 9484776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
    Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
    Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular mechanisms of malignant conversion in skin carcinogenesis.
    Yuspa SH; Greenhalgh DA
    Princess Takamatsu Symp; 1989; 20():281-8. PubMed ID: 2518687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive expression of erbB2 in epidermis of transgenic mice results in epidermal hyperproliferation and spontaneous skin tumor development.
    Kiguchi K; Bol D; Carbajal S; Beltrán L; Moats S; Chan K; Jorcano J; DiGiovanni J
    Oncogene; 2000 Aug; 19(37):4243-54. PubMed ID: 10980598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal expression of transforming growth factor-alpha in transgenic mice: induction of spontaneous and 12-O-tetradecanoylphorbol-13-acetate-induced papillomas via a mechanism independent of Ha-ras activation or overexpression.
    Wang XJ; Greenhalgh DA; Eckhardt JN; Rothnagel JA; Roop DR
    Mol Carcinog; 1994 May; 10(1):15-22. PubMed ID: 8185825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blocking transforming growth factor beta signaling in transgenic epidermis accelerates chemical carcinogenesis: a mechanism associated with increased angiogenesis.
    Go C; Li P; Wang XJ
    Cancer Res; 1999 Jun; 59(12):2861-8. PubMed ID: 10383147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activator protein 1 transcription factors are fundamental to v-rasHa-induced changes in gene expression in neoplastic keratinocytes.
    Rutberg SE; Adams TL; Glick A; Bonovich MT; Vinson C; Yuspa SH
    Cancer Res; 2000 Nov; 60(22):6332-8. PubMed ID: 11103794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transgenic mice expressing targeted HPV-18 E6 and E7 oncogenes in the epidermis develop verrucous lesions and spontaneous, rasHa-activated papillomas.
    Greenhalgh DA; Wang XJ; Rothnagel JA; Eckhardt JN; Quintanilla MI; Barber JL; Bundman DS; Longley MA; Schlegel R; Roop DR
    Cell Growth Differ; 1994 Jun; 5(6):667-75. PubMed ID: 7522035
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.